Focusing the neuroscience and societal implications of cognitive enhancers

G Savulich, T Piercy, AB Bruhl, C Fox, J Suckling, JB Rowe, JT O'Brien, BJ Sahakian

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)
4 Downloads (Pure)

Abstract

Cognitive enhancement can benefit the individual and society, but also has associated risks and ethical concerns. Cognitive-enhancing drugs are used in the treatment of neuropsychiatric disorders. Non-pharmacological strategies are also emerging, which have the potential to improve motivational deficits associated with neuropsychiatric symptoms and should be prioritized for development. The increasing lifestyle use of ‘smart’ and other drugs indicates the desire for healthy people to improve themselves. Safety and ethical implications are discussed.
Original languageEnglish
Pages (from-to)170–172
Number of pages3
JournalClinical Pharmacology and Therapeutics
Volume101
Issue numberDesigner Drugs 2.0
Early online date23 Sep 2016
DOIs
Publication statusPublished - Feb 2017

Cite this